The information in this website is intended only for healthcare professionals. By entering this site, you are confirming that you are a healthcare professional.
The information in this website is intended only for laboratory professionals. By entering this site, you are confirming that you are a laboratory professional.
ImmunoCAP™ Allergen Components, which are purified native or recombinant proteins, offer the opportunity to assess a person's allergen sensitization pattern at the molecular level. Different component groups often elicit different types of reactions, so testing them can indicate if a patient's prior symptoms or positive test results were caused by allergy to a given substance or by a cross-reaction with another allergen. Test results with allergen components also help the clinician weigh a patient's risk of systemic reaction versus a more mild or localized response.
Manufactured using recombinant or native purified material, more than 100 ImmunoCAP Allergen Components are available, including components from:
Canonica GW, Ansotegui IJ, Pawankar R, et al. A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6(1):17.
Some products may not be available to you, and indications may differ from your original region's approved use.
Global
